Registration Dossier

Diss Factsheets

Administrative data

Key value for chemical safety assessment

Genetic toxicity in vitro

Description of key information

Bacterial reverse mutation test:

An in vitro gene mutation study in bacteria according to OECD 471 and GLP with the registered substance (CAS 93-08-3) is ongoing. Test results will be submitted after receiving the final study report.

In vitro mammalian cell chromosome aberration test:

An in vitro cytogenicity study according to OECD 473 and GLP with the registered substance (CAS 93-08-3) is ongoing.Test results will be submitted after receiving the final study report.

In vitro gene mutation test in mammalian cell:

An in vitro gene mutation study in mammalian cells according to OECD 476 and GLP with the registered substance (CAS 93-08-3) is ongoing.Test results will be submitted after receiving the final study report.

 

Link to relevant study records

Referenceopen allclose all

Endpoint:
in vitro gene mutation study in bacteria
Data waiving:
other justification
Justification for data waiving:
other:
Justification for type of information:
This information will be submitted later based on the ECHA communication number CCH-D-2114501340-71-01/F.
Endpoint:
in vitro cytogenicity / chromosome aberration study in mammalian cells
Data waiving:
other justification
Justification for data waiving:
other:
Justification for type of information:
This information will be submitted later based on the ECHA communication number CCH-D-2114501340-71-01/F.
Endpoint:
in vitro gene mutation study in mammalian cells
Data waiving:
other justification
Justification for data waiving:
other:
Justification for type of information:
This information will be submitted later based on the ECHA communication number CCH-D-2114501340-71-01/F.
Endpoint conclusion
Endpoint conclusion:
no study available

Genetic toxicity in vivo

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed (negative)

Additional information

Justification for classification or non-classification

In vitro gene mutation studies in bacterial and mammalian cells according to OECD 471 and OECD 476 are ongoing with the registered substance (CAS 93-08-3). Also, an in vitro cytogenicity study according to OECD 473 with the registered substance (CAS 93-08-3) is running. Hence, justification for classification or non-classification will be added upon receiveng these test results.